BUSINESS
Why have MFs fallen in love with Mankind Pharma just a month since its listing?
BUSINESS
Top life insurers turn bullish on healthcare stocks; investments higher than sector weightage in Nifty 100
BUSINESS
Riches to rags: How the pharma growth story faltered over the decade?
BUSINESS
Max, Fortis set for robust earnings growth on new CGHS rates: Jefferies
BUSINESS
KIE sees margin expansion for Sun Pharma despite high R&D spends
BUSINESS
What are the implications of the govt's ban on 14 fixed-dose combination drugs?
BUSINESS
Why contract drug manufacturers meet FDA norms easily while others struggle
BUSINESS
Know your stock | Why are analysts upbeat on KIMS?
BUSINESS
Apollo Hospitals' occupancy to reach 70%, Apollo 24*7 on path to breakeven: MD
BUSINESS
Why are brokerages divided over Torrent Pharma’s outlook despite a strong Q4 show?
BUSINESS
Mazagon Dock Shipbuilders surges 5% on robust quarterly show
BUSINESS
Apollo Hospitals gains 2% on hopes of strong Q4 earnings
BUSINESS
Sun Pharma Preview: Strong specialty biz, robust domestic sales to boost company’s health in Q4
BUSINESS
Fed officials divided over support for more rate hikes, FOMC meet minutes show
BUSINESS
Gland Pharma’s prospects after dismal earnings fail to impress investors
BUSINESS
Is dual drug filing the right tactic for pharma companies now?
BUSINESS
Delayed drug launches to hurt Cipla’s earnings in FY24
BUSINESS
Expect EBITDA margin to sustain at 25-30% in FY24, says Meghmani Finechem CMD Maulik Patel
BUSINESS
Cipla's Q4 net profit surges 45% on year to Rs 525.65 crore, lags estimate
BUSINESS
Closing Bell: Sensex up 123 points, Nifty above 18,330; M&M, IndusInd, Axis Bank top gainers
BUSINESS
Cipla Q4 preview: Robust domestic traction, gRevlimid sales likely to give earnings a big boost
BUSINESS
Dr Reddy's fall 5% even after Q4 net profit jumps 10-fold. Here's why
BUSINESS
Closing Bell: Indices close marginally lower; Dr Reddy's, L&T, Hindalco, Divi's Lab top losers
BUSINESS
Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
